Published on in Vol 7 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/40437, first published .
Patient Feedback on a Mobile Medication Adherence App for Buprenorphine and Naloxone: Closed and Open-Ended Survey on Feasibility and Acceptability

Patient Feedback on a Mobile Medication Adherence App for Buprenorphine and Naloxone: Closed and Open-Ended Survey on Feasibility and Acceptability

Patient Feedback on a Mobile Medication Adherence App for Buprenorphine and Naloxone: Closed and Open-Ended Survey on Feasibility and Acceptability

Journals

  1. McPherson S, Smith C, Hall L, Miguel A, Bowden T, Keever A, Schmidt A, Olson K, Rodin N, McDonell M, Roll J, LeBrun J. Mobile Medication Adherence Platform for Buprenorphine (MAP4BUP): A Phase I feasibility, usability and efficacy pilot randomized clinical trial. Drug and Alcohol Dependence 2024;256:111099 View
  2. Nieto O, Rosen A, Kalmin M, Li L, Shoptaw S, Jenkins S, Zarei Ardestani Z, Tulu B. Adoption of a Digital Health Tool for Opioid Use Disorder Treatment in Primary Care: Facilitators and Challenges (Preprint). Journal of Medical Internet Research 2024 View